Smoking Cessation for Depression and Anxiety Treatment

• Status: Completed
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary aim of this research study is to enhance smoking cessation outcome among smokers with elevated anxiety and depression. We are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cessation, and anxiety and depression management treatment program (SDAT). Both treatments also utilize nicotine replacement therapy.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Houston
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• Ages 18-65 years old

• Capable of providing informed consent

• Willing to attend all study visits and comply with the protocol

• Daily smoker for at least one year

• Currently smoke an average of at least 6 cigarettes per day

• Report a motivation to quit smoking in the next 6 weeks of at least 5 on a 10-point scale

• Elevated anxiety or depression

Exclusion Criteria:

• Use of other tobacco products

• Current or past psychotic disorders of any type, or comorbid psychiatric conditions that are relative or absolute contraindications to the use of any treatment option in the study protocol

• Currently suicidal or high suicide risk

• Current use of any pharmacotherapy or psychotherapy for smoking cessation not provided by the researchers during the quit attempt

• Concurrent psychotherapy initiated within three months of baseline, or ongoing psychotherapy of any duration directed specifically toward the treatment of anxiety or depression

• Current or intended participation in a concurrent substance abuse treatment

• Current non-nicotine substance dependence

• Insufficient command of English to participate in assessment or treatment